Boston Scientific Corp., in a filing with the US Securities And Exchange Commission on Tuesday, said it has entered into a Stipulation of Settled Issues with the Internal Revenue Service or IRS. This is intended to resolve all disputes related to the previously disclosed transfer pricing issues for Guidant Corp.'s 2001 through 2006 tax years and Boston Scientific’s 2006 and 2007 tax years currently before the United States Tax Court.
The Stipulation of Settled Issues is contingent upon the IRS Office of Appeals applying the same basis of settlement to all transfer pricing issues for the Company’s 2008 through 2010 tax years and, if applicable, review by the United States Congress Joint Committee on Taxation.
